ROLE OF IL-1 AXIS IN SENSITIZED AIRWAY SMOOTH MUSCLE
IL-1 轴在敏感气道平滑肌中的作用
基本信息
- 批准号:6389856
- 负责人:
- 金额:$ 23.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:antibody receptor asthma autocrine beta adrenergic receptor bronchomotion clinical research cyclic AMP cytokine cytokine receptors fluorescent dye /probe human subject inflammation inositol phosphates interleukin 1 laboratory rabbit pathologic process phlebotomy polymerase chain reaction receptor coupling respiratory hypersensitivity smooth muscle
项目摘要
Bronchial asthma is characterized by airway inflammation, exaggerated airway narrowing to bronchoconstrictor agonists and attenuated responsiveness to beta-adrenoceptor-mediated airway relaxation. Various cytokines have been implicated in the pathogenesis of the inflammatory response in asthmatic airways, and specific cytokines, most notably IL-1beta, have also been shown to directly regulate airway smooth muscle (ASM) responsiveness. In view of the latter, together with our recent observations demonstrating an important autocrine role for IL-1beta in coupling Fc receptor activation and changes in ASM responsiveness in the atopic asthmatic sensitized state, this proposal is designed to examine the role of the IL-1 axis of molecules (i.e., IL-1alpha, IL-1beta, IL-1RI, -RII, IL-1ra, and ICE), in mediating the altered functional and proinflammatory phenotype that characterizes the atopic asthmatic sensitized ASM. Accordingly, studies are proposed to examine the interrelated hypotheses that: I: The human ASM constitutes an autocrine environment which, when activated in the atopic (IgE-mediated) sensitized state, induces the autologous elaboration of various molecules constituting the IL-1 axis and; II: These molecules play an interactive role in the autocrine induction of altered ASM responsiveness, as well as in the altered expression and release of specific TH1- and TH2-type cytokines and their receptors in the atopic sensitized state. Accordingly, the Specific Aims of this project are to: I) examine the autologously- induced altered expression of the IL-1 axis and determine the role of activation of specific Fc receptors in inducing the altered expression of the IL-1 axis of molecules in the atopic sensitized state; 2) examine the role and mechanism of altered induced expression of the IL-1 axis in mediating changes in ASM responsiveness in the atopic sensitized state, and assess the presence of induced altered receptor/G protein-coupled expression and action, as well as agonist-mediated accumulation of the principal second messengers, inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and cAMP; and 3) examine the autocrine regulatory interactions between altered expression of the IL-1 axis and the TH2-type cytokines IL-4, IL-5 and GM-CSF, and the TH1-type cytokines, IL-2, IL-12 and IFN-gamma, and their receptors and to determine whether the above TH1- and TH2-type cytokines also exert a reciprocal modulatory action on the autocrine expression of the IL-1 axis of molecules. We anticipate that the results from our proposed studies will elucidate the role and mechanism of action of the IL-1 axis in the development of the "pro-asthmatic" ASM phenotype.
支气管哮喘的特征是气道炎症、对支气管收缩剂激动剂的气道过度狭窄以及对β-肾上腺素受体介导的气道松弛的反应减弱。多种细胞因子与哮喘气道炎症反应的发病机制有关,并且特定细胞因子,尤其是 IL-1β,也被证明可以直接调节气道平滑肌 (ASM) 反应性。鉴于后者,加上我们最近的观察表明 IL-1β 在耦合 Fc 受体激活和特应性哮喘致敏状态下 ASM 反应性变化中具有重要的自分泌作用,本提案旨在检查 IL-1β 的作用分子轴(即 IL-1α、IL-1β、IL-1RI、-RII、IL-1ra 和 ICE),介导功能改变和促炎表型的特征特应性哮喘致敏 ASM。因此,提出研究来检验以下相互关联的假设: I:人类 ASM 构成了一个自分泌环境,当在特应性(IgE 介导的)致敏状态下被激活时,会诱导构成 IL-1 轴的各种分子的自体合成; II:这些分子在 ASM 反应性改变的自分泌诱导以及特应性致敏状态下特定 TH1 和 TH2 型细胞因子及其受体的表达和释放改变中发挥相互作用。因此,该项目的具体目标是:I) 检查自体诱导的 IL-1 轴表达改变,并确定特定 Fc 受体的激活在诱导 IL-1 轴分子表达改变中的作用。特应性敏感状态; 2) 检查IL-1轴诱导表达改变在介导特应性敏感状态下ASM反应性变化中的作用和机制,并评估诱导改变的受体/G蛋白偶联表达和作用以及激动剂的存在-介导主要第二信使肌醇 1,4,5-三磷酸 (Ins(1,4,5)P3) 和 cAMP 的积累; 3) 检查 IL-1 轴表达改变与 TH2 型细胞因子 IL-4、IL-5 和 GM-CSF 以及 TH1 型细胞因子 IL-2、IL-12 和 GM-CSF 之间的自分泌调节相互作用。 IFN-γ及其受体,并确定上述TH1型和TH2型细胞因子是否也对分子IL-1轴的自分泌表达发挥相互调节作用。我们预计我们提出的研究结果将阐明 IL-1 轴在“促哮喘”ASM 表型发展中的作用和作用机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hakon Hakonarson其他文献
Hakon Hakonarson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hakon Hakonarson', 18)}}的其他基金
Utilizing Polygenic Risk to Understand and Improve Outcomes: A Model For Overturning Health Disparities Through Minority-Enriched Genomics Healthcare
利用多基因风险来理解和改善结果:通过少数族裔丰富的基因组医疗保健推翻健康差异的模型
- 批准号:
10852564 - 财政年份:2020
- 资助金额:
$ 23.45万 - 项目类别:
Utilizing Polygenic Risk to Understand and Improve Outcomes: A Model For Overturning Health Disparities Through Minority-Enriched Genomics Healthcare
利用多基因风险来理解和改善结果:通过少数族裔丰富的基因组医疗保健推翻健康差异的模型
- 批准号:
10207724 - 财政年份:2020
- 资助金额:
$ 23.45万 - 项目类别:
The Future of Genomics Medicine in Patient Care: Contributions from CHOP
基因组学医学在患者护理中的未来:CHOP 的贡献
- 批准号:
9282527 - 财政年份:2015
- 资助金额:
$ 23.45万 - 项目类别:
The Future of Genomics Medicine in Patient Care: Contributions from CHOP
基因组学医学在患者护理中的未来:CHOP 的贡献
- 批准号:
9480307 - 财政年份:2015
- 资助金额:
$ 23.45万 - 项目类别:
The Future of Genomics Medicine in Patient Care: Contributions from CHOP
基因组学医学在患者护理中的未来:CHOP 的贡献
- 批准号:
9902001 - 财政年份:2015
- 资助金额:
$ 23.45万 - 项目类别:
The Future of Genomics Medicine in Patient Care: Contributions from CHOP
基因组学医学在患者护理中的未来:CHOP 的贡献
- 批准号:
9272117 - 财政年份:2015
- 资助金额:
$ 23.45万 - 项目类别:
Integrative Genomic Analyses of NMDA Receptor Pathway in Schizophrenia
精神分裂症 NMDA 受体通路的综合基因组分析
- 批准号:
8887155 - 财政年份:2014
- 资助金额:
$ 23.45万 - 项目类别:
3/3-Networks from Multidimensional Data for Schizophrenia and Related Disorders
3/3-来自精神分裂症和相关疾病多维数据的网络
- 批准号:
8501691 - 财政年份:2012
- 资助金额:
$ 23.45万 - 项目类别:
3/3-Networks from Multidimensional Data for Schizophrenia and Related Disorders
3/3-来自精神分裂症和相关疾病多维数据的网络
- 批准号:
8666061 - 财政年份:2012
- 资助金额:
$ 23.45万 - 项目类别:
Integrative Analysis of a GWAS Repository with EMRs from over 40,000 Children
对 GWAS 存储库与 40,000 多名儿童的 EMR 进行综合分析
- 批准号:
8514179 - 财政年份:2012
- 资助金额:
$ 23.45万 - 项目类别:
相似国自然基金
DNA损伤感应器蛋白MRE11调控气道上皮cGAS-STING通路参与哮喘2型炎症的机制研究
- 批准号:82300029
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微塑料通过MALT1促进巨噬细胞M1极化加重哮喘的机制研究
- 批准号:82300021
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PFKFB3介导的糖酵解通过诱导气道上皮细胞功能失调加重哮喘气道炎症和气道重塑的机制
- 批准号:82300041
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
CD207阳性树突状细胞在过敏性哮喘气道炎症中作用及机制研究
- 批准号:82370035
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Modulation of Chronic Th2 inflammation by the CCR8 Receptor-Ligand Pathway
CCR8 受体-配体途径对慢性 Th2 炎症的调节
- 批准号:
10055847 - 财政年份:2016
- 资助金额:
$ 23.45万 - 项目类别:
Modulation of Chronic Th2 inflammation by the CCR8 Receptor-Ligand Pathway
CCR8 受体-配体途径对慢性 Th2 炎症的调节
- 批准号:
9239296 - 财政年份:2016
- 资助金额:
$ 23.45万 - 项目类别:
Therapeutic Strategies for Environmental Lung Diseases
环境性肺病的治疗策略
- 批准号:
7295871 - 财政年份:2007
- 资助金额:
$ 23.45万 - 项目类别:
Therapeutic Strategies for Environmental Lung Diseases
环境性肺病的治疗策略
- 批准号:
7491197 - 财政年份:2007
- 资助金额:
$ 23.45万 - 项目类别:
Molecular transduction of the mechanical environment in airway epithelium
气道上皮机械环境的分子转导
- 批准号:
7164424 - 财政年份:2006
- 资助金额:
$ 23.45万 - 项目类别: